Literature DB >> 29445881

Study of salivary and serum vaspin and total antioxidants in anorexia nervosa.

Elzbieta Paszynska1, Marta Tyszkiewicz-Nwafor2, Agnieszka Slopien2, Monika Dmitrzak-Weglarz3, Agata Dutkiewicz2, Teresa Grzelak4.   

Abstract

OBJECTIVES: Patients with anorexia nervosa (AN) are primarily at high risk of multiple somatic complications, including oral diseases. In recent years, a number of new molecules that may play a potentially important role in AN progress and prognosis have been identified in saliva, but their exact roles are still poorly understood. Two such group of substances are antioxidants and vaspin. The purpose of this observational, cross-sectional study was to measure both the salivary and serum total antioxidant status (TAS), and vaspin (VASP) concentrations of patients with AN in comparison to an average population.
MATERIAL AND METHODS: Ninety subjects participated (30 patients with AN, 60 matched healthy control subjects). A clinical examination was made, and blood and salivary samples were taken during the acute stage of AN (BMI < 15 kg/m2) in the first week of hospitalization. Enzyme immunoassay (ELISA) suitable for measuring VASP and colorimetric assay for TAS were used.
RESULTS: Anorexic patients had significant reductions in salivary flow, TAS, and an elevation in VASP levels in their saliva and serum. Significant correlations between TAS, VASP, salivary flow, and nutritional status were detected.
CONCLUSION: Determination of TAS and VASP in combined biological material confirmed that saliva might be a reliable non-invasive source of information for potent nutritional biomarkers. CLINICAL RELEVANCE: Our findings suggest that VASP cannot be excluded, as its increased concentration in saliva is an adaptive mechanism in reduced TAS, one resulting from diminished salivary secretion. It is therefore worth conducting further research aimed at recognizing the role of TAS and VASP in the saliva of underweight patients.

Entities:  

Keywords:  Adaptive mechanism; Anorexia nervosa; Antioxidants; Biomarkers; Transformation; Vaspin

Mesh:

Substances:

Year:  2018        PMID: 29445881     DOI: 10.1007/s00784-018-2370-9

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  57 in total

1.  Characterization of the differentiated antioxidant profile of human saliva.

Authors:  Rafael M Nagler; Ifat Klein; Nataly Zarzhevsky; Noam Drigues; Abraham Z Reznick
Journal:  Free Radic Biol Med       Date:  2002-02-01       Impact factor: 7.376

2.  Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.

Authors:  Nora Klöting; Janin Berndt; Susan Kralisch; Peter Kovacs; Mathias Fasshauer; Michael R Schön; Michael Stumvoll; Matthias Blüher
Journal:  Biochem Biophys Res Commun       Date:  2005-11-15       Impact factor: 3.575

Review 3.  Omentin: a novel link between inflammation, diabesity, and cardiovascular disease.

Authors:  Bee K Tan; Raghu Adya; Harpal S Randeva
Journal:  Trends Cardiovasc Med       Date:  2010-07       Impact factor: 6.677

4.  Salivary alpha-amylase, secretory IgA and free cortisol as neurobiological components of the stress response in the acute phase of anorexia nervosa.

Authors:  E Paszynska; M Dmitrzak-Weglarz; M Tyszkiewicz-Nwafor; A Slopien
Journal:  World J Biol Psychiatry       Date:  2016-04-29       Impact factor: 4.132

Review 5.  Eating disorders in women's oral health.

Authors:  D Studen-Pavlovich; M A Elliott
Journal:  Dent Clin North Am       Date:  2001-07

Review 6.  Metals, toxicity and oxidative stress.

Authors:  M Valko; H Morris; M T D Cronin
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

Review 7.  Effect of periodontal treatment on adipokines in type 2 diabetes.

Authors:  Hiroshi Ogawa; Teerasak Damrongrungruang; Sayaka Hori; Kaname Nouno; Kumiko Minagawa; Misuzu Sato; Hideo Miyazaki
Journal:  World J Diabetes       Date:  2014-12-15

8.  Association of macrophage inhibitory cytokine-1 with nutritional status, body composition and bone mineral density in patients with anorexia nervosa: the influence of partial realimentation.

Authors:  Ivana Dostálová; Petra Kaválková; Hana Papežová; Daniela Domluvilová; Vít Zikán; Martin Haluzík
Journal:  Nutr Metab (Lond)       Date:  2010-04-23       Impact factor: 4.169

Review 9.  Vaspin (serpinA12) in obesity, insulin resistance, and inflammation.

Authors:  John T Heiker
Journal:  J Pept Sci       Date:  2014-03-05       Impact factor: 1.905

10.  Antioxidant activity and nutritional status in anorexia nervosa: effects of weight recovery.

Authors:  María-Jesús Oliveras-López; Inmaculada Ruiz-Prieto; Patricia Bolaños-Ríos; Francisco De la Cerda; Franz Martín; Ignacio Jáuregui-Lobera
Journal:  Nutrients       Date:  2015-03-30       Impact factor: 5.717

View more
  4 in total

1.  Risk of Dental Caries and Erosive Tooth Wear in 117 Children and Adolescents' Anorexia Nervosa Population-A Case-Control Study.

Authors:  Elzbieta Paszynska; Amadeusz Hernik; Agnieszka Slopien; Magdalena Roszak; Katarzyna Jowik; Monika Dmitrzak-Weglarz; Marta Tyszkiewicz-Nwafor
Journal:  Front Psychiatry       Date:  2022-05-10       Impact factor: 5.435

2.  Neuropeptide B and Vaspin as New Biomarkers in Anorexia Nervosa.

Authors:  Teresa Grzelak; Marta Tyszkiewicz-Nwafor; Agata Dutkiewicz; Aniceta Ada Mikulska; Monika Dmitrzak-Weglarz; Agnieszka Slopien; Krystyna Czyzewska; Elzbieta Paszynska
Journal:  Biomed Res Int       Date:  2018-06-10       Impact factor: 3.411

3.  Expression of salivary immunoglobulins and their association with analgesic neuropeptide opiorphin in anorexia nervosa during adolescence.

Authors:  Elzbieta Paszynska; Amadeusz Hernik; Agnieszka Slopien; Yves Boucher; Marta Tyszkiewicz-Nwafor; Magdalena Roszak; Karolina Bilska; Monika Dmitrzak-Weglarz
Journal:  J Eat Disord       Date:  2022-08-11

Review 4.  Anorexia Nervosa and the Immune System-A Narrative Review.

Authors:  Dennis Gibson; Philip S Mehler
Journal:  J Clin Med       Date:  2019-11-08       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.